It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pancreatic β-cells are prone to endoplasmic reticulum (ER) stress due to their role in insulin secretion. They require sustainable and efficient adaptive stress responses to cope with this stress. Whether episodes of chronic stress directly compromise β-cell identity is unknown. We show here under reversible, chronic stress conditions β-cells undergo transcriptional and translational reprogramming associated with impaired expression of regulators of β-cell function and identity. Upon recovery from stress, β-cells regain their identity and function, indicating a high degree of adaptive plasticity. Remarkably, while β-cells show resilience to episodic ER stress, when episodes exceed a threshold, β-cell identity is gradually lost. Single cell RNA-sequencing analysis of islets from type 1 diabetes patients indicates severe deregulation of the chronic stress-adaptation program and reveals novel biomarkers of diabetes progression. Our results suggest β-cell adaptive exhaustion contributes to diabetes pathogenesis.
Pancreatic β-cells are naturally prone to ER stress due to their role in insulin production and secretion. Here, the authors show that chronic ER stress adaptive exhaustion results in an irreversible loss of β-cell function leading to T1D pathogenesis
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 Case Western Reserve University, Department of Genetics and Genome Sciences, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
2 Case Western Reserve University, Department of Biochemistry, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
3 University of Pennsylvania Perelman School of Medicine, Department of Genetics and Institute for Diabetes, Obesity and Metabolism, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
4 University of Michigan Medical Center, The Division of Metabolism, Endocrinology & Diabetes, Ann Arbor, USA (GRID:grid.412590.b) (ISNI:0000 0000 9081 2336)
5 Cleveland Clinic, Lerner Research Institute, Cleveland, US (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725)
6 University of Wisconsin-Madison, School of Medicine and Public Health, Department of Biomolecular Chemistry, Madison, USA (GRID:grid.14003.36) (ISNI:0000 0001 2167 3675)
7 University of Florida College of Medicine, Department of Pathology, Immunology and Laboratory Medicine, Gainesville, US (GRID:grid.15276.37) (ISNI:0000 0004 1936 8091)
8 University of Tennessee, Department of Medicine, Memphis, US (GRID:grid.267301.1) (ISNI:0000 0004 0386 9246)
9 Case Western Reserve University, Department of Biochemistry, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); The Hebrew University of Jerusalem, The Institute for Drug Research, Jerusalem, Israel (GRID:grid.9619.7) (ISNI:0000 0004 1937 0538)
10 University of Wisconsin-Madison, School of Medicine and Public Health, Department of Biomolecular Chemistry, Madison, USA (GRID:grid.14003.36) (ISNI:0000 0001 2167 3675); University of Wisconsin-Madison, School of Medicine and Public Health, Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, Madison, USA (GRID:grid.14003.36) (ISNI:0000 0001 2167 3675)